Abstract
Infective endocarditis (IE) is a relatively uncommon but potentially life-threatening infection of the cardiac endothelium. Most cases of infective endocarditis in children occur in those with congenital heart disease or who have had prior cardiac surgery. Most cases in adults occur on non-native valves and abnormal native valves, but infective endocarditis can involve normal heart valves and can occur in children and adults without identifiable risk factors. Gram-positive organisms, namely, Staphylococcus aureus and viridans group streptococci, are the most common causes of IE. HACEK organisms, enterococcus, pneumococcus, and, rarely, coagulase-negative staphylococci and non-HACEK gram-negative pathogens are also reported. Culture-negative endocarditis caused by atypical pathogens is also reported in children and adults. Signs and symptoms associated with infective endocarditis are often non-specific which can lead to a delay in diagnosis. Fever and cardiac murmurs are common features of infective endocarditis. Subacute presentations of illness are common in patients with infective endocarditis, but an acute presentation with rapid progression of sepsis-like illness can occur, especially with S. aureus. Diagnosis of infective endocarditis is based on clinical features, microbiological evidence, and echocardiographic findings. There is a role for molecular diagnostic studies in culture-negative cases. Urgent evaluation and management of hemodynamic status is critical in patients with infective endocarditis. Empirical antimicrobial therapy for infective endocarditis is based on the patient’s age, risk factors, comorbidities, and local antimicrobial susceptibility patterns. Recommendations from the American Heart Association can be used to guide treatment decisions for infective endocarditis, and specialist consultation should be considered. Prolonged antimicrobial therapy is recommended for infective endocarditis. Surgical intervention is necessary for some patients with infective endocarditis. Prevention of infective endocarditis by utilizing antibiotics prior to dental and certain other surgical procedures is only indicated for those with unrepaired cyanotic congenital heart disease or surgically repaired congenital heart disease with residual shunt or device, in those with a prosthetic heart valve, in cardiac transplant recipients and valvulopathy, and in those who have been previously diagnosed and treated for endocarditis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baltimore RS, Gewitz M, Baddour LM, Beerman LB, Jackson MA, Lockhart PB, et al. Infective endocarditis in childhood: 2015 update: a scientific statement from the American Heart Association. Circulation. 2015;132(15):1487–515.
Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736–54.
Paharik AE, Horswill AR. The staphylococcal biofilm: Adhesins, regulation, and host response. Microbiol Spectr. 2016;4(2). https://doi.org/10.1128/microbiolspec.VMBF-0022-2015.
Pasquali SK, He X, Mohamad Z, McCrindle BW, Newburger JW, Li JS, et al. Trends in endocarditis hospitalizations at US children's hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines. Am Heart J. 2012;163(5):894–9.
Levasseur S, Saiman L. Endocarditis and other intravascular infections. In: Long SS, Prober CG, Fischer M, editors. Principles and Practice of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA: Elsevier; 2018.
Starke JR, Endocarditis I. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry's textbook of pediatric infectious diseases. 7th ed. Philadelphia, PA: Elsevier; 2014.
Gupta S, Sakhuja A, McGrath E, Asmar B. Trends, microbiology, and outcomes of infective endocarditis in children during 2000-2010 in the United States. Congenit Heart Dis. 2017;12(2):196–201.
Feder HM Jr, Roberts JC, Salazar J, Leopold HB, Toro-Salazar O. HACEK endocarditis in infants and children: two cases and a literature review. Pediatr Infect Dis J. 2003;22(6):557–62.
Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service Am J Med. 1994;96(3):200–9.
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.
Further Reading
Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association. Circulation. 2015;132(15):1487–515.
Infective Endocarditis in Adults. Diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–86.
Prevention of Infective Endocarditis. Guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Norton, L.E., Jackson, M.A. (2019). Infective Endocarditis. In: Domachowske, J. (eds) Introduction to Clinical Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-91080-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-91080-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91079-6
Online ISBN: 978-3-319-91080-2
eBook Packages: MedicineMedicine (R0)